BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND KLF6, RP11-184A2_1, 1316, ENSG00000067082, ST12, DKFZp686N0199, CPBP, Zf9, COPEB, ZF9, PAC1, GBF, BCD1
40870 results:

  • 1. Germline Pathogenic Variants in Patients With pancreatic and Periampullary cancers.
    Ando Y; Dbouk M; Yoshida T; Abou Diwan E; Saba H; Dbouk A; Yoshida K; Roberts NJ; Klein AP; Burkhart R; He J; Hruban RH; Goggins M
    JCO Precis Oncol; 2024 May; 8():e2400101. PubMed ID: 38781545
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
    Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
    Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
    Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
    Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
    Arias-Lorza AM; Costello JR; Hingorani SR; Von Hoff DD; Korn RL; Raghunand N
    Sci Rep; 2024 May; 14(1):11570. PubMed ID: 38773189
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of peritumoral tissue analysis in predicting characteristics of hepatocellular carcinoma using ultrasound-based radiomics.
    Qian H; Huang Y; Xu L; Fu H; Lu B
    Sci Rep; 2024 May; 14(1):11538. PubMed ID: 38773179
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.
    Yamada R; Kuriyama N; Tanaka T; Nose K; Nakamura Y; Miwata T; Tsuboi J; Mizuno S; Nakagawa H
    BMC Gastroenterol; 2024 May; 24(1):174. PubMed ID: 38769494
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.
    Han F; Dong S; Chen Z; Dong C; Shi H; Du Y; Zhou W
    Pak J Pharm Sci; 2024 Mar; 37(2):327-336. PubMed ID: 38767100
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway.
    Zhou S; Wang Z; Zhao D; Fu Y; Zhang S; Wang Z; Zou X
    World J Surg Oncol; 2024 May; 22(1):133. PubMed ID: 38762741
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Non-specific uptake of
    Li Y; Gao J; Li Y; Duan X; Shen C
    Sci Rep; 2024 May; 14(1):11141. PubMed ID: 38750103
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    de Graaff MR; Hendriks TE; Wouters M; Nielen M; de Hingh I; Koerkamp BG; van Santvoort HC; Busch OR; den Dulk M; Klaase JM; van Zwet E; Bonsing BA; Grünhagen DJ; Besselink MG; Kok NFM
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38747683
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
    Yuan Y; Li S; Yan M; Yang Y; Zhong C; Hu Y
    BMC Pulm Med; 2024 May; 24(1):235. PubMed ID: 38745167
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
    Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
    BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for pancreatic Ductal Adenocarcinoma.
    Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
    Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
    [No Abstract]    [Full Text] [Related]  

  • 15. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer.
    Zhang J; Yang J; Li X; Mao L; Zhang Y; Liu Y; Bao Y
    Mol Genet Genomics; 2024 May; 299(1):51. PubMed ID: 38743077
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
    Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
    Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
    Chen J; Li L; Feng Y; Zhao Y; Sun F; Zhou X; Yiqi D; Li Z; Kong F; Kong X
    Cell Biol Toxicol; 2024 May; 40(1):30. PubMed ID: 38740637
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles.
    Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B
    Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pancreatic GHRHomas in Patients with or without Multiple Endocrine Neoplasia Type 1 (MEN 1) : An Analysis of 36 Reported Cases.
    Yamasaki R
    J Med Invest; 2024; 71(1.2):1-8. PubMed ID: 38735704
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Standard Nutritional Assessment Tools Are Unable to Predict Loss of Muscle Mass in Patients Due to Undergo pancreatico-Duodenectomy: Highlighting the Need for Detailed Nutritional Assessment.
    Phillips ME; Robertson MD; Bennett-Eastley K; Rowe L; Frampton AE; Hart KH
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732516
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2044.